Clinical Trial Update: Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating cilostazol-aspirin therapy for preventing recurrent stroke in intracranial artery stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Stroke

Drugs mentioned

• cilostazol-aspirin

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Cerebrovascular Disease | Phase 3 | Status: COMPLETED